MicroRNA‑373 exerts anti‑tumor functions in human liver cancer by targeting Rab22a

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Liver cancer is a prevalent global malignancy.
• MicroRNAs play critical roles in cancer development and progression.
• The specific function of microRNA-373 (miR-373) in liver cancer requires further elucidation.

Purpose of the Study:

• To investigate the role of miR-373 in liver cancer development and progression.
• To assess the potential of miR-373 as a prognostic biomarker for liver cancer patients.

Main Methods:

• Quantitative reverse transcription PCR to measure miR-373 levels in tumor and adjacent tissues.
• Statistical analysis (chi-squared, Kaplan-Meier, multivariate analysis) to correlate miR-373 with clinicopathological features and prognosis.
• In vitro functional assays (transfection, proliferation, migration, invasion, luciferase assays) in liver cancer cell lines (Hep3B, HepG2).

Main Results:

• miR-373 expression was significantly downregulated in liver cancer tissues compared to normal tissues.
• Lower miR-373 levels were associated with poorer clinical prognosis.
• Overexpression of miR-373 inhibited proliferation and invasion of liver cancer cells.
• miR-373 directly targeted and inhibited the Ras-related protein Rab22a oncoprotein.

Conclusions:

• miR-373 exhibits anti-tumor effects in liver cancer by suppressing cell proliferation and invasion.
• miR-373 acts as a tumor suppressor by inhibiting the Rab22a signaling pathway.
• miR-373 is a potential prognostic biomarker for liver cancer.